Documente Academic
Documente Profesional
Documente Cultură
Summary
During the second half of 2010,
the Basel Committee on Banking
Supervision (BCBS) has provided
further clarification and quantification
of the required global standards for
capital and liquidity. In this briefing
we summarise the new regulations
and look at their impact.
B
ack in 2009, in response to the finan-
cial crisis, the BCBS published two
papers that set out major revisions
and enhancements to the Basel II frame-
work. These were followed in December of
the same year by two consultation papers
on capital and liquidity.
T
he following summary identifies what the old regulations but do not meet the new
new regulations are due to be intro- CRD IV (consultation phase) directive will cease to qualify in 2013 but
duced and when they will take effect, • Consistent with BCBS December 2009 can be grandfathered out over 10 years.
as well as those proposals that are still under- Papers This will provide the opportunity for non-
going consultation. A key change is that the • Subject to amendments proposed in joint-stocks companies or others without
application of the Capital Requirements July and September 2010 following the share capital (such as the Landesbanks
Directive III (CRD III) has now been pushed consultation process and the mutual building societies) to meet
back to December 2011. Full implementation • Including the Countercyclical Buffer ‘Basel III’ while making the necessary
of CRD IV is now between 2013 and 2019. consistent with the BCBS 2009 paper adjustments over an extended timescale. In
• Implementation proposed between 2013 addition, capital instruments that no longer
Technical Provisions Amendment and 2019 qualify as non-common equity Tier 1 or Tier
Directive (adopted July 2009) 2 instruments will also be phased out over
• New rules on significant risk transfer ten years.
(SRT), not in Basel II
• Risk weighting of liquidity facilities Common equity transition
increased • January 2013: common equity with no
• Member states required to apply from regulatory adjustments applied
31 December 2010
Regulatory deductions
Impact key: high; medium; low.
Additional Tier 1 Capital 2.0% 1.0% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%
Total Tier 1 Capital 4.0% 4.5% 5.5% 6.0% 6.6% 7.3% 7.9% 8.5%
Tier 2 Capital 4.0% 3.5% 2.5% 2.0% 2.0% 2.0% 2.0% 2.0%
Minimum Total Capital 8.0% 8.0% 8.0% 8.0% 8.6% 9.3% 9.9% 10.5%
W
hile Basel II addressed only capital • Requirement to meet the LCR for each
requirements, ‘Basel III’ has wid- currency where a net outflow exists Considerations
ened the scope. For the first time • Off balance sheet commitments would
ever, it attempts to set out a global liquidity Transition need to be 5% pre-funded
requirement. At the heart of this are two new • January 2015 (observation phase from • There will be additional requirements
ratios to ensure adequate short-term and January 2011 – may require reporting where concentrations exist
longer-term liquidity. from this date) • Is a consolidated level requirement
• Local regulators may set early adoption
Liquidity coverage ratio (LCR) Transition
This is designed to ensure that a bank has • January 2018 (observation phase from
a minimum level of short-term liquidity to Basel III’ sets out, for the January 2012, but proposals subject to
change)
remain solvent over 30 calendar days of
acute liquidity stress. This will be deter-
first time, a global liquidity
mined by their having an adequate level of requirement. N.B. The need to fund off balance sheet
unencumbered, high-quality assets that are commitments is a key factor and will lead to
convertible into cash to fund net outflows. significant costs for banking clients who use
Net stable funding ratio (NSFR) these facilities. The BCBS has accepted that
One of the most contentious aspects of this proposal requires more work and it is
Formula
‘Basel III’, the NSFR has been subject to likely to change significantly.
_ 100%
Stock of high-quality liquid assets >
significant ‘watering down’ by the Basel
Net outflows over a 30-day period
committee, and is most likely to change fur-
ther prior to implementation. It is designed
to ensure that banks have sufficient long-
FY10 implied surplus/deficit (in 000,000’s EUR) for a 7% ‘go to’ Common Equity Tier 1
20,000
15,000
10,000
5,000
-5,000
-10,000
1
Standardised Approach
Must be subordinated to depositor and general creditors Introduction of global liquidity standards for • Gain or losses on MTM of own liabilities
internationally active banks, including a 30-day liquidity • 50:50 deductions to be 1,250% RW
Tier 3 Capital coverage ratio and a 1-year net stable funding ratio
• U
nconsolidated FIs, mortgage servicing rights and
To be abolished deferred tax assets due to timing differences. Single
item and aggregate concentrations limit apply
1
Standardised Approach
capital for them. However, in doing so they balance sheet because of the leverage
Impact assessment have the benefit of both a 10-year ‘grand- ratio, their capital base because of the new
fathering’ period and a new certainty about definition, and their liquidity in both the short
Better the devil you know?
the exact requirements they need to meet. and longer term.
T
he expectation is that many banks The implementation challenge Even though the final stages of the Basel II
already hold the minimum capital With many of the most contentious areas now amendments contain little in the way of
requirements and that, for most of addressed and quantified, banks at last shocks or surprises, they still constitute a
those who do not, it will not be a major know where they stand in relation to ‘Basel major implementation challenge. This must
stretch. This is likely to drive banks toward III’. So, having been focused equally on both be met while banks also deal with the exist-
early adoption. It is worth noting, however, the need to change and the impact, they can ing imperatives of rebuilding their capital
that regulators will be encouraged not to now concentrate on implementation. and customer bases, and meeting their
permit those who are already ‘overmeeting’ lending obligations to the market. So in
the requirements to erode their capital to This will not, however, be a simple task. As many ways, now that the dust has settled,
minimum levels. they spend the next six months recalibrating the real work has only just begun.
their three and five year forecasts to take
Institutions such as the German into account the impact of the new require-
Landesbanks and mutual building societies ments, they will have many different areas
will have to readdress what constitutes to focus on. For example, their gross
T
he IASB continues the process of Capital
drafting and phasing-in IFRS 9, the Key impacts The new accounting rules look set to
replacement standard for IAS 39. This Key changes are: impact on retained earnings, and therefore
will not be finalised until the middle of 2011, • Generally simpler classification and on banks capital requirements. This is
with full implementation due to begin in measurement approaches and a single because, under ‘Basel III’, retained earn-
January 2013. However, many believe this impairment method ings are now a key component of common
will slip back into 2014. This appears to be • Non-vanilla financial assets will be sub- equity. As a result banks will need to care-
a realistic assessment as it will need to go ject to MtM accounting fully consider IFRS 9’s impact on their ability
through the EU parliament in its entirety • Subordinated securitisation assets will to meet the new regulations on capital.
before it can become law. be subject to MtM accounting (a partial
Liquidity
reversal of the 2008 reclassifications)
The proposals IFRS 9 changes could affect the ability
• No subsequent reclassification
The IASB’s open project to replace IAS 39 of, and means by which, banks maintain
• Establishment of countercyclical provi-
with IFRS 9 comprises three phases: their liquidity. This is because by changing
sions for credit losses (an expected loss
• Phase 1: Classification and measurement the classification of some funding instru-
impairment approach)
• Phase 2: Impairment methodology ments to ‘mark to market’, their attractive-
• Increased disclosure requirements
• Phase 3: Hedge accounting ness to buyers may reduce. Banks must
• Potential for significant asset derecogni-
carefully consider how best to assess
tion and derivative exposure recognition
The EU is yet to endorse any of these pro- and address these impacts.
posals, awaiting publication of all phases The chart below illustrates the timings and
summaries of what these key changes are.
Reclassification Expected
When an entity changes business model for
managing financial assets it must reclassify
all affected assets using the amortised cost
conditions.
OCI option
At initial recognition, can elect to recognise
MtM movements in equity instruments in OCI.
Investment must not have been made for
trading.
Cannot be reclassified out of OCI.
Embedded derivatives
Component of a hybrid instrument with a
non-derivative host; entire contract to be
fair valued.
If the host is not covered under IFRS 9, it is
classified in line with its appropriate IFRS,
while the derivative is bifurcated and
classified as above.
‘Basel III’ and IFRS 9 7
Portugal
Focused on your priorities Contacts Adriana Leal
+34 91 438 5252
A tailored approach to delivering Global Solutions adriana.leal@rbs.com
RBS’s solutions expertise. Nick Pudney
+44 (0)20 7085 4386 Italy
A
t RBS we are fully committed to nick.pudney@rbs.com Francesco Rizzo
understanding our clients’ needs +44 (0)20 7085 0401
and those of the markets in which Matt Read francesco.rizzo@rbs.com
they operate. Our strong individual client +44 (0)20 7085 2314
relationships are backed by the expertise, matt.read@rbs.com Germany & Austria
scale and reach of a global bank. Stefan Krasz
David Simonson +49 69 2690 6233
We hope that this update has provided you +44 (0)20 7085 4276 stefan.krasz@rbs.com
with a useful guide to the requirements of david.simonson@rbs.com
both the ‘Basel III’ and IFRS 9 regulatory Greece
and accounting reforms. However, we real- Solutions Sales Konstantinos Diamantopoulos
ise that you may have specific questions or UK +44 (0)20 7085 0037
concerns that need to be dealt with on an Nick Wrightson konstantinos.diamantopoulos@rbs.com
individual basis. We would be pleased to +44 (0)20 7085 2780
discuss these with you and support you in nick.wrightson@rbs.com Nordic Region
developing plans and strategies to best Carl Lithander
manage the implementation and risk man- France +44 (0)20 7085 9356
agement of the transition to both ‘Basel III’ Emmanuel Delattre carl.lithander@rbs.com
and IFRS 9. +44 (0)20 7085 5677
emmanuel.delattre@rbs.com The Netherlands
If you would like to discuss any of the issues CJ Welkzijn
raised in this briefing, please contact your Spain +31 20 464 2491
local sales team or regular RBS contact. Luis Torroba cjwelkzijn@rbs.com
+34 91 438 5146
luis.torroba@rbs.com
Patricio Silva
+34 91 438 52 58
patricio.silva@rbs.com
The contents of this document are indicative and are subject to change without notice. This document is intended for your sole use on the basis that before entering into this, and/or any
related transaction, you will ensure that you fully understand the potential risks and return of this, and/or any related transaction and determine it is appropriate for you given your objectives,
experience, financial and operational resources, and other relevant circumstances. You should consult with such advisers as you deem necessary to assist you in making these determinations.
Both The Royal Bank of Scotland plc and The Royal Bank of Scotland N.V. (“RBS”) will not act and has not acted as your legal, tax, regulatory, accounting or investment adviser or owe
any fiduciary duties to you in connection with this, and/or any related transaction and no reliance may be placed on RBS for investment advice or recommendations of any sort. RBS
makes no representations or warranties with respect to the information and disclaims all liability for any use you or your advisers make of the contents of this document. However this
shall not restrict, exclude or limit any duty or liability to any person under any applicable laws or regulations of any jurisdiction which may not lawfully be disclaimed.
Where the document is connected to Over The Counter (“OTC”) financial instruments you should be aware that OTC derivatives (“OTC Derivatives”) can provide significant benefits but
may also involve a variety of significant risks. All OTC Derivatives involve risks which include (inter-alia) the risk of adverse or unanticipated market, financial or political developments,
risks relating to the counterparty, liquidity risk and other risks of a complex character. In the event that such risks arise, substantial costs and/or losses may be incurred and operational
risks may arise in the event that appropriate internal systems and controls are not in place to manage such risks. Therefore you should also determine whether the OTC transaction is
appropriate for you given your objectives, experience, financial and operational resources, and other relevant circumstances.
RBS and its affiliates, connected companies, employees or clients may have an interest in financial instruments of the type described in this document and/or in related financial instruments.
Such interest may include dealing in, trading, holding, or acting as market-makers in such instruments and may include providing banking, credit and other financial services to any
company or issuer of securities or financial instruments referred to herein.
RBS plc is authorised and regulated in the UK by the Financial Services Authority. The Royal Bank of Scotland plc. Registered in Scotland No. 90312. Registered Office: 36 St Andrew
Square, Edinburgh EH2 2YB.
The Royal Bank of Scotland N.V., established in Amsterdam, The Netherlands. Registered with the Chamber of Commerce in The Netherlands, No. 33002587. Authorised by De Nederlandsche
Bank N.V. and regulated by the Authority for the Financial Markets in The Netherlands. Contact for The Royal Bank of Scotland N.V. Niederlassung Deutschland and The Royal Bank of
Scotland plc. Frankfurt Branch is Junghofstr. 22, 60311 Frankfurt am Main.
The financial instruments described in this document are made in compliance with an applicable exemption from the registration requirements of the US Securities Act of 1933.
The Royal Bank of Scotland plc acts in certain jurisdictions as the authorised agent of The Royal Bank of Scotland N.V.